Dr. Yi Song's Research Studies Published in Clinical Cancer Research and Nature Medicine
Sep 29, 2024
The Department of Surgery congratulates Dr. Yi Song on her recent publications in
Clinical Cancer Research and Nature Medicine.
From 2021 to 2023, Dr. Song conducted two years of dedicated research within the Hepato-Pancreato-Biliary
(HPB) Division at Memorial Sloan Kettering Cancer Center. Her work on the genetic
profiling of intrahepatic cholangiocarcinoma has been recognized as a pivotal contribution
in the field of surgical oncology. Intrahepatic cholangiocarcinoma is highly heterogeneous
compared to other biliary tumors, such as extrahepatic cholangiocarcinoma and gallbladder
cancer. By utilizing a machine-learning-based statistical algorithm, Dr. Song revealed
that intrahepatic cholangiocarcinoma spans a genetic spectrum. At one end, it mirrors the genetic characteristics of extrahepatic cholangiocarcinoma
or gallbladder cancer, while at the other end, its genetic profile closely resembles
hepatocellular carcinoma. This novel genomic classification surpasses current histopathologic
methods in prognostic accuracy. Her findings have enhanced the understanding of this
complex tumor’s biology and clinical behavior, providing valuable insights for therapeutic
decision-making. This study earned Dr. Song the Best Basic Science Research Paper
of the Year and Best Oral Abstract Award in the HPB track from the Society of Surgical
Oncology (SSO) in 2023. It was also presented during the Plenary Session at the 2023
SSO annual meeting in Boston. This study was published in Clinical Cancer Research
(DOI: 10.1158/1078-0432.CCR-24-0657).
Additionally, during her research fellowship, Dr. Song collaborated with translational
scientists at Weill Cornell School of Medicine to investigate the liver's microenvironment
and its role in fostering metastatic niches for pancreatic cancer cells. Their study,
which analyzed liver biopsies from 49 pancreatic cancer patients and 19 control patients,
identified critical differences in immune and cellular features between patients who
later developed metastasis and those who did not. This ground-breaking research was
published in Nature Medicine (DOI: 10.1038/s41591-024-03075-7).
Dr. Song’s contributions continue to shape the field of surgical oncology, offering significant advancements in cancer research and patient care. Please congratulate Dr. Song for her achievements.